PROCEPT BioRobotics Statistics
Total Valuation
PRCT has a market cap or net worth of $2.64 billion. The enterprise value is $2.46 billion.
| Market Cap | 2.64B |
| Enterprise Value | 2.46B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, after market close.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PRCT has 50.96 million shares outstanding. The number of shares has increased by 6.43% in one year.
| Shares Outstanding | 50.96M |
| Shares Change (YoY) | +6.43% |
| Shares Change (QoQ) | +4.80% |
| Owned by Insiders (%) | 3.62% |
| Owned by Institutions (%) | 91.61% |
| Float | 43.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.38 |
| Forward PS | 12.31 |
| PB Ratio | 9.40 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.28.
| Current Ratio | 7.63 |
| Quick Ratio | 6.65 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.51 |
Financial Efficiency
Return on equity (ROE) is -46.60% and return on invested capital (ROIC) is -30.33%.
| Return on Equity (ROE) | -46.60% |
| Return on Assets (ROA) | -30.60% |
| Return on Capital (ROIC) | -30.33% |
| Revenue Per Employee | $217,558 |
| Profits Per Employee | -$169,165 |
| Employee Count | 626 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.12% in the last 52 weeks. The beta is 1.01, so PRCT's price volatility has been similar to the market average.
| Beta (1Y) | 1.01 |
| 52-Week Price Change | +40.12% |
| 50-Day Moving Average | 49.04 |
| 200-Day Moving Average | 39.21 |
| Relative Strength Index (RSI) | 58.12 |
| Average Volume (30 Days) | 458,290 |
Short Selling Information
The latest short interest is 4.65 million, so 9.12% of the outstanding shares have been sold short.
| Short Interest | 4.65M |
| Short Previous Month | 4.12M |
| Short % of Shares Out | 9.12% |
| Short % of Float | 10.59% |
| Short Ratio (days to cover) | 9.14 |
Income Statement
In the last 12 months, PRCT had revenue of $136.19 million and -$105.90 million in losses. Loss per share was -$2.24.
| Revenue | 136.19M |
| Gross Profit | 71.05M |
| Operating Income | -109.17M |
| Pretax Income | -105.90M |
| Net Income | -105.90M |
| EBITDA | -98.08M |
| EBIT | -101.90M |
| Loss Per Share | -$2.24 |
Balance Sheet
The company has $257.22 million in cash and $79.20 million in debt, giving a net cash position of $178.02 million or $3.49 per share.
| Cash & Cash Equivalents | 257.22M |
| Total Debt | 79.20M |
| Net Cash | 178.02M |
| Net Cash Per Share | $3.49 |
| Equity / Book Value | 280.75M |
| Book Value Per Share | 5.51 |
| Working Capital | 304.64M |
Cash Flow
In the last 12 months, operating cash flow was -$108.00 million and capital expenditures -$25.21 million, giving a free cash flow of -$133.21 million.
| Operating Cash Flow | -108.00M |
| Capital Expenditures | -25.21M |
| Free Cash Flow | -133.21M |
| FCF Per Share | -$2.82 |
Margins
Gross margin is 52.17%, with operating and profit margins of -80.16% and -77.76%.
| Gross Margin | 52.17% |
| Operating Margin | -80.16% |
| Pretax Margin | -77.76% |
| Profit Margin | -77.76% |
| EBITDA Margin | -72.02% |
| EBIT Margin | -74.82% |
| FCF Margin | -97.81% |
Dividends & Yields
PRCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.43% |
| Shareholder Yield | -6.43% |
| Earnings Yield | -4.01% |
| FCF Yield | -5.05% |
Analyst Forecast
The average price target for PRCT is $45.83, which is -11.51% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $45.83 |
| Price Target Difference | -11.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 32.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRCT has an Altman Z-Score of 11.61 and a Piotroski F-Score of 2.
| Altman Z-Score | 11.61 |
| Piotroski F-Score | 2 |